Xiaoxia Ma
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Xiaoxia Ma has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Yijun Meng
College of Life and Environmental Sciences Hangzhou Normal University Hangzhou China
2 shared publications Aiqin Gao
Department of Oncology, Jinan Central Hospital Affiliated to Shandong University, Jinan 250013, China
1 shared publication- Aiwen Dong
Key Laboratory of Hunan Forest Products and Chemical Industry Engineering, Jishou University, Zhangjiajie 427000, China
1 shared publication - Chaogang Shao
Affiliation College of Life Sciences, Huzhou University, Huzhou, Zhejiang, P.R. China
1 shared publication - Hang Xiao
College of Biosystems Engineering and Food Science, Zhejiang University, Hangzhou 310058, China; Department of Food Science, University of Massachusetts, Amherst 01003, USA
1 shared publication Hongyu Li
Department of Medical Insurance, Jinan Central Hospital Affiliated to Shandong University, Jinan 250013, China
1 shared publication
Latest Publications
- Open Access
- 27 April 2022
- Published by Wiley in The Plant Genome
- Vol. 15 (2) , e20210
An organ‐specific transcriptomic atlas of the medicinal plant Bletilla striata : Protein‐coding genes, microRNAs, and regulatory networks
As one of the important species belonging to the Bletilla genus of Orchidaceae, Bletilla striata (Thunb.) Rchb. f., possesses both ornamental and medicinal values. Its dried tubers are used as a traditional Chinese medicine, and several secondary metabolites have been indicated to be the active ingredients. However, the molecular mechanisms related to the regulation of secondary metabolism have not been characterized in B. striata . In this study, integrated analysis of RNA sequencing (RNA‐seq), small RNA sequencing (sRNA‐seq), and degradome sequencing (degradome‐seq) data from three organs (leaf, root, and tuber) of B. striata provided us with a comprehensive view of the microRNA (miRNA)‐mediated regulatory network. Firstly, based on the RNA‐seq data, the organ‐specific expression patterns of the protein‐coding genes, especially for those related to secondary metabolism, were investigated. Secondly, 342 conserved miRNA candidates were identified from B. striata . These miRNAs were assigned to 88 families, some of which were selected for expression pattern analysis. Additionally, 31 hairpin‐structured precursors encoding 23 novel miRNAs were uncovered from the transcriptome assembly. Thirdly, based on the degradome signatures, 1,142 validated miRNA–target pairs (involving 167 conserved miRNAs and six novel miRNAs and 51 target genes) were included in the regulatory network. Organ‐specific expression level comparison between the miRNAs and their targets revealed some interesting miRNA–target pairs. Fourthly, some valuable subnetworks were extracted for further functional studies. Additionally, some regulatory pathways were indicated to be monocot specific. Summarily, our results lay a solid basis for in‐depth studies on the regulatory mechanisms underlying the production of the medicinal ingredients in B. striata .
- 27 April 2022
- Published by Wiley in The Plant Genome
- Vol. 15 (2) , e20210
Open AccessAn organ‐specific transcriptomic atlas of the medicinal plant Bletilla striata : Protein‐coding genes, microRNAs, and regulatory networks
As one of the important species belonging to the Bletilla genus of Orchidaceae, Bletilla striata (Thunb.) Rchb. f., possesses both ornamental and medicinal values. Its dried tubers are used as a traditional Chinese medicine, and several secondary metabolites have been indicated to be the active ingredients. However, the molecular mechanisms related to the regulation of secondary metabolism have not been characterized in B. striata . In this study, integrated analysis of RNA sequencing (RNA‐seq), small RNA sequencing (sRNA‐seq), and degradome sequencing (degradome‐seq) data from three organs (leaf, root, and tuber) of B. striata provided us with a comprehensive view of the microRNA (miRNA)‐mediated regulatory network. Firstly, based on the RNA‐seq data, the organ‐specific expression patterns of the protein‐coding genes, especially for those related to secondary metabolism, were investigated. Secondly, 342 conserved miRNA candidates were identified from B. striata . These miRNAs were assigned to 88 families, some of which were selected for expression pattern analysis. Additionally, 31 hairpin‐structured precursors encoding 23 novel miRNAs were uncovered from the transcriptome assembly. Thirdly, based on the degradome signatures, 1,142 validated miRNA–target pairs (involving 167 conserved miRNAs and six novel miRNAs and 51 target genes) were included in the regulatory network. Organ‐specific expression level comparison between the miRNAs and their targets revealed some interesting miRNA–target pairs. Fourthly, some valuable subnetworks were extracted for further functional studies. Additionally, some regulatory pathways were indicated to be monocot specific. Summarily, our results lay a solid basis for in‐depth studies on the regulatory mechanisms underlying the production of the medicinal ingredients in B. striata .
- 1 February 2022
- Published by Elsevier in Journal of Plant Physiology
- Vol. 270, 153636
Creating and maintaining a high-confidence microRNA repository for crop research: A brief review and re-examination of the current crop microRNA registries
- 1 February 2022
- Published by Elsevier in Journal of Plant Physiology
- Vol. 270, 153636
Creating and maintaining a high-confidence microRNA repository for crop research: A brief review and re-examination of the current crop microRNA registries
- Open Access
- 1 January 2016
- Published by Wiley in Disease Markers
- Vol. 2016, 1-9
Prognostic Value of Perineural Invasion in Esophageal and Esophagogastric Junction Carcinoma: A Meta-Analysis
Objective. Here we aimed to clarify the prognostic significance of perineural invasion (PNI) in esophageal and esophagogastric junction (EGJ) carcinoma.Methods. A comprehensive literature search for relevant reports published up to July 2015 was performed using Pubmed and Embase databases. The pooled HR and 95% CI for overall survival (OS) and disease-free survival (DFS) were used to assess the prognostic value. The association of PNI with pathological characteristics was evaluated by OR and 95% CI.Results. A total of 13 cohorts were retrieved, covering 2770 patients treated by surgery. The cumulative analysis revealed a statistical correlation between PNI and poor OS (HR = 1.76, 95% CI: 1.54–2.20, and), as well as poor DFS (HR = 1.96, 95% CI: 1.42–2.71, and). Moreover, analysis of 1475 patients showed improved PNI in T3 + T4 (OR = 0.39, 95% CI: 0.21–0.70, and), N+ (OR = 0.52, 95% CI: 0.40–0.69, and), and G3 + G4 (OR = 0.66, 95% CI: 0.48–0.90, and) patients compared with T1 + T2, N−, and G1 + G2 ones, respectively. No significant heterogeneity was found between the studies.Conclusions. PNI is an adverse prognostic biomarker in esophageal and EGJ carcinoma. Moreover, PNI implies advanced T, N stage and poor cell differentiation.- 1 January 2016
- Published by Wiley in Disease Markers
- Vol. 2016, 1-9
Open AccessPrognostic Value of Perineural Invasion in Esophageal and Esophagogastric Junction Carcinoma: A Meta-Analysis
Objective. Here we aimed to clarify the prognostic significance of perineural invasion (PNI) in esophageal and esophagogastric junction (EGJ) carcinoma.Methods. A comprehensive literature search for relevant reports published up to July 2015 was performed using Pubmed and Embase databases. The pooled HR and 95% CI for overall survival (OS) and disease-free survival (DFS) were used to assess the prognostic value. The association of PNI with pathological characteristics was evaluated by OR and 95% CI.Results. A total of 13 cohorts were retrieved, covering 2770 patients treated by surgery. The cumulative analysis revealed a statistical correlation between PNI and poor OS (HR = 1.76, 95% CI: 1.54–2.20, and), as well as poor DFS (HR = 1.96, 95% CI: 1.42–2.71, and). Moreover, analysis of 1475 patients showed improved PNI in T3 + T4 (OR = 0.39, 95% CI: 0.21–0.70, and), N+ (OR = 0.52, 95% CI: 0.40–0.69, and), and G3 + G4 (OR = 0.66, 95% CI: 0.48–0.90, and) patients compared with T1 + T2, N−, and G1 + G2 ones, respectively. No significant heterogeneity was found between the studies.Conclusions. PNI is an adverse prognostic biomarker in esophageal and EGJ carcinoma. Moreover, PNI implies advanced T, N stage and poor cell differentiation.